KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,502,703 | -40.9% | 8,887 | -24.2% | 0.00% | -50.0% |
| Q2 2023 | $2,542,784 | +28.3% | 11,726 | +7.4% | 0.00% | +100.0% |
| Q1 2023 | $1,982,601 | -7.5% | 10,915 | +0.0% | 0.00% | -50.0% |
| Q4 2022 | $2,144,209 | +21.8% | 10,912 | +39.5% | 0.00% | +100.0% |
| Q3 2022 | $1,760,000 | +85.9% | 7,823 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $947,000 | +0.1% | 7,483 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $946,000 | -1.0% | 7,462 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $956,000 | -23.2% | 7,293 | -28.3% | 0.00% | 0.0% |
| Q3 2021 | $1,245,000 | +11.6% | 10,176 | +4.0% | 0.00% | 0.0% |
| Q2 2021 | $1,116,000 | 0.0% | 9,786 | +5.4% | 0.00% | 0.0% |
| Q1 2021 | $1,116,000 | +15.6% | 9,283 | -2.3% | 0.00% | 0.0% |
| Q4 2020 | $965,000 | +132.0% | 9,499 | +76.5% | 0.00% | – |
| Q3 2020 | $416,000 | -54.5% | 5,381 | -34.4% | 0.00% | -100.0% |
| Q2 2020 | $914,000 | – | 8,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |